Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/5/2008
 
First Published:
10/9/2008
1.
Phase I/II Pilot Study of Carbon-11 Acetate Positron Emission Tomography and 3-Tesla Magnetic Resonance Imaging in Patients With Localized Prostate Cancer Undergoing Prostatectomy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Diagnostic
Active
18 and over
NCI
NCI-08-C-0226
08-C-0226, NCI-P07280, NCT00771550
Last Modified:
4/1/2008
 
First Published:
7/15/2005
2.
Diagnostic Study of Positron Emission Tomography Using Carbon-11 Acetate in Detecting Metastasis and Predicting Recurrence in Patients With Newly Diagnosed Prostate Cancer at Medium or High Risk for Recurrence After Initial Curative Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 to 90
NCI
WU-03-0315
NCT00121212
Last Modified:
5/15/2007
 
First Published:
10/21/2006
3.
Pilot Study of Carbon-11 Acetate and Fludeoxyglucose F 18 Positron Emission Tomography Imaging of Bone in Patients With Bone-Dominant Metastatic Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Treatment
Active
18 and over
Other
UWCC-UW-6129
UWCC-06-0500-H/A, FHCRC-6129, NCT00392938
4.
11C-Acetate PET/CT Non-FDG-Avid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 to 90
Other
TASMC-08-EE-109-CTIL
NCT00687778
5.
Multi-Tracer PET Assessment of Primary Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 and over
Other
HCI # 31335
NCT00813566
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute